Abstract
Earlier works have revealed increased generation of reactive oxygen species (ROS) and decreased antioxidant levels in type 1 diabetes mellitus (T1DM). The current study aimed to investigate the effect of mixed insulin therapy on oxidative stress and antioxidant status in patients with T1DM. This study involved 75 participants who were divided into three groups: 20 healthy subjects as a control, 25 newly diagnosed patients with T1DM (without treatment) and 30 patients with T1DM treated with insulin (regular and Human Neutral Protamine Hagedorn (NPH)) twice daily. Fasting serum glucose (FSG), serum concentrations of insulin, malondialdehyde (MDA), catalase (CAT), reduced glutathione (GSH), and vitamins (C and E) were measured in all participants. Compared with the healthy control, serum glucose and MDA concentrations were observed to be significantly higher, while significantly lower concentrations of CAT, GSH, and vitamins (C and E) were found in both the treated and untreated diabetic groups. Although insulin therapy caused a significant decrease in blood sugar with a marked elevation in the levels of insulin, CAT, GSH and vitamin E compared to the untreated patients, the changes in the levels of MDA and vitamin C between diabetic groups were not significant. Moreover, the level of insulin resistance was significantly increased in insulin-treated patients as compared to the control and untreated diabetic groups. In conclusion, twice daily treatment with regular and NPH insulin can ameliorate hyperglycemia and improve antioxidant levels in patients with T1DM. However, the insulin regimen used in this study did not reveal a beneficial effect on oxidative stress and insulin resistance. Hence, exogenous antioxidants (vitamins C and E) can be used in combination with insulin to control these parameters.
Highlights
Type 1 diabetes mellitus (T1DM) is a long-term metabolic disease marked by hyperglycemia and lower levels of insulin due to pancreatic β-cell dysfunction (Simmons and Michels 2015)
22.1 ± 0.5 In Table 2, newly diagnosed and insulin-treated diabetic patients showed significantly higher Fasting serum glucose (FSG) and lower insulin levels compared to the control group
Concerning HOMA-IR, the untreated diabetic group showed a comparable level to the control, while the administration of insulin resulted in a significant increase compared with the other groups
Summary
Type 1 diabetes mellitus (T1DM) is a long-term metabolic disease marked by hyperglycemia and lower levels of insulin due to pancreatic β-cell dysfunction (Simmons and Michels 2015). Oxidative stress occurs in T1DM due to excessive formation of reactive oxygen species (ROS), mainly superoxide anion and hydroxyl radicals, and a simultaneous reduction in antioxidant capacity (Evans et al 2002; Ceriello 2006). Persistent hyperglycemia contributes to a sharp rise in ROS production, which in turn results in β-cell destruction and eventually an impairment of insulin production and secretion (Thongnak et al 2017).
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
